Examining melanoma under a microscope transforms a simple diagnosis into a detailed investigation of cellular behavior. Pathologists analyze tissue samples to determine the depth of invasion, cellular atypia, and mitotic activity, which directly influence treatment planning and prognosis. This microscopic evaluation is the definitive method for confirming malignancy and classifying the specific subtype of the disease.
The Diagnostic Workflow: From Biopsy to Report
The journey begins with a biopsy, where a sample of suspicious tissue is extracted using either an excisional or incisional method. Once the specimen reaches the laboratory, a dermatopathologist or surgical pathologist processes the tissue through fixation, embedding in paraffin, and slicing into thin sections. These sections are stained with hematoxylin and eosin (H&E), which highlights the cell nuclei in dark purple and the cytoplasm in pink, allowing for clear visualization of the melanoma cells against the surrounding tissue landscape.
Assessing Architectural Patterns
Under low magnification, the pathologist evaluates the overall architecture of the lesion. They look for asymmetry, irregular borders, and a nested or pagetoid growth pattern. Melanoma often disrupts the orderly arrangement of the epidermis, invading downward into the dermis in a haphazard manner. This initial survey provides the context needed to identify the areas requiring high-power examination.
Evaluating Cytological Features
Switching to high magnification, the focus shifts to the individual cells. Key features include significant nuclear pleomorphism, where the nuclei vary greatly in size and shape, and prominent nucleoli, which appear as dense, dark structures within the nucleus. The chromatin pattern is often coarse and uneven, and mitotic figures—cells undergoing division—are counted to determine the proliferation rate. The presence of these features distinguishes melanoma from benign nevi, where cells are uniform and organized.
Critical Measurements and Classifications
One of the most critical measurements is the Breslow thickness, which quantifies the vertical distance from the top of the granular layer to the deepest point of tumor invasion. This measurement is a major prognostic factor, as thicker tumors correlate with a higher risk of metastasis. Additionally, the presence of a tumor-infiltrating lymphocyte (TIL) response is noted, as this indicates the body's immune reaction to the cancer cells.
Ancillary Testing for Molecular Insights
While histology provides the primary diagnosis, ancillary testing is increasingly important for treatment planning. Immunohistochemical stains, such as S100, HMB-45, and Melan-A, help confirm the melanocytic lineage of the tumor cells. Furthermore, molecular profiling is now standard practice to identify mutations in genes like BRAF, NRAS, and KIT. These results determine whether a patient is eligible for targeted therapies or immunotherapies, making the microscopic examination a gateway to precision medicine.
